EL Forge (531144)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹22.8 |
| Market Cap | ₹46.35 Cr |
| P/E Ratio | 17.29 |
| ROCE | 11.17% |
| ROE | 7.4% |
| Dividend Yield | 0% |
| Profit Growth | -8.93% |
| Debt/Equity | — |
| Sales Growth | 6.27% |
| 52-Week Range | ₹12.1 — ₹23.4 |
| Sector | Auto Components |
| Book Value | ₹11.63 |
Strengths
- Sales grew 6.27%, indicating some demand in the auto components space
- ROCE of 11.17% is higher than ROE, showing the operating capital base is generating a reasonable return
- Latest quarter is profitable: ₹1 Cr net profit on ₹20 Cr sales
- Book value of ₹11.63 gives a tangible asset reference below the current market price
Concerns
- Profit growth is -8.93%, so earnings are declining despite modest sales growth
- Piotroski F-Score of 4/9 points to weak financial health
- ROE of only 7.40% is too low for a quality compounder
- No dividend, and insufficient data on debt/equity and promoter holding reduces transparency
AI Analysis
Looking at EL Forge, I am reminded that a low price tag is not the same as a bargain. At ₹22.80, the entire company is worth only ₹46 Cr, but small size does not forgive weak economics. The business earns a 7.40% ROE and an 11.17% ROCE—hardly the hallmark of a franchise with pricing power or a wide moat. Sales grew 6.27%, yet profits fell 8.93%. That divergence worries me; growth that does not reach the bottom line is low-quality growth. The latest quarter shows ₹20 Cr of sales and just ₹1 Cr of net profit—a thin margin that leaves little room for error. Book value is ₹11.63, so I am paying 1.96 times book for a company whose earnings are contracting. A P/E of 17.29 with negative profit growth and a PEG of 2.76 offers no margin of safety. There is no dividend, so I receive no income while waiting for uncertain appreciation. The Piotroski score of 4/9 reinforces my caution: the financial health is weak. Auto components is a cyclical industry, and this appears to be a cyclical business in a soft patch. Graham taught me to buy with a margin of safety, but I do not see it here. The 52-week range of ₹12.10 to ₹23.40 tells me the market itself has swung widely in valuing this share. I would need evidence of consistent profit growth, improving returns on equity, and a cleaner balance sheet before I could call this an investment. Until then, EL Forge stays in the too-difficult pile. I would rather miss an opportunity than overpay for mediocrity.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer